Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Nanotechnology|September 20, 2016
Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancerAmy Pan, Hongyong Zhang, Yuanpei Li, et al.
International Journal of Molecular Sciences|November 27, 2021
Genome-Wide Identification of the Xyloglucan endotransglucosylase/Hydrolase (XTH) and Polygalacturonase (PG) Genes and Characterization of Their Role in Fruit Softening of Sweet CherryZefeng Zhai, Chen Feng, Yanyan Wang, et al.
Horticulture Research|May 21, 2025
Strigolactones enhance apple drought resistance via the MsABI5-MsSMXL1-MsNAC022 cascadeXiang Zhang, BingYang Du, Maihemuti Turupu, et al.
Translational Lung Cancer Research|September 27, 2019
The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patientsHuijuan Li, Yangyang Xu, Bing Wan, et al.
International Journal of Molecular Sciences|January 11, 2022
Functions of COP1/SPA E3 Ubiquitin Ligase Mediated by MpCRY in the Liverwort Marchantia polymorpha under Blue LightLi Zhang, Tianhong Li, Shengzhong Su, et al.
Pediatric Rheumatology Online Journal|January 30, 2024
Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotypePeiwei Zhao, Juan Huang, Huicong Fu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Large-scale screening and molecular characterization of EML4-ALK fusion variants in archival non-small-cell lung cancer tumor specimens using quantitative reverse transcription polymerase chain reaction assaysTianhong Li, Martin K H Maus, Sonal J Desai, et al.
Biomarker Research|January 17, 2023
Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectivesLuis A Godoy, Joy Chen, Weijie Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2006
Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamideJoseph A Sparano, Stacy Moulder, Aslamuzzaman Kazi, et al.
Frontiers in Immunology|August 28, 2023
Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometryWeijie Ma, Sixi Wei, Siqi Long, et al.
Pageof 13